Association of Beta-Blocker Use and Selectivity With Outcomes in Patients With Heart Failure and Chronic Obstructive Pulmonary Disease (from OPTIMIZE-HF)

2012/11/29 by Robert J. Mentz, Daniel Wojdyla, Mona Fiuzat +4 · 18 citations
Medicine · #Heart Failure Treatment and Management #Chronic Obstructive Pulmonary Disease (COPD) Research #Cardiovascular and exercise physiology

paper · doi:10.1016/j.amjcard.2012.10.041

Cited by

• Noncardiac comorbidities and acute heart failure patients. [europepmc]
• New advances in beta-blocker therapy in heart failure. [europepmc]
• Noncardiac comorbidities in heart failure with reduced versus preserved ejection fraction. [europepmc]
• Underuse of β-blockers in heart failure and chronic obstructive pulmonary disease. [europepmc]
• Effect of β-blockade on lung function, exercise performance and dynamic hyperinflation in people with arterial vascular disease with and without COPD. [europepmc]
• Breathlessness, but not cough, suggests chronic obstructive pulmonary disease in elderly smokers with stable heart failure. [europepmc]
• Beta-blocker therapy in patients with COPD: a systematic literature review and meta-analysis with multiple treatment comparison. [europepmc]
• Impact of beta-blocker use on the long-term outcomes of heart failure patients with chronic obstructive pulmonary disease. [europepmc]
• Preventing adverse cardiac events (PACE) in chronic obstructive pulmonary disease (COPD): study protocol for a double-blind, placebo controlled, randomised controlled trial of bisoprolol in COPD. [europepmc]
• Beta-Blocker Use in Older Hospitalized Patients Affected by Heart Failure and Chronic Obstructive Pulmonary Disease: An Italian Survey From the REPOSI Register. [europepmc]
• 2022 Guidelines of the Taiwan Society of Cardiology and the Taiwan Hypertension Society for the Management of Hypertension. [europepmc]
• Assessment of the right ventricular strain, left ventricular strain and left atrial strain using speckle tracking echocardiography in patients with chronic obstructive pulmonary disease. [europepmc]
• Appraisal of β-Blocker Use in Patients with Cardiovascular Disease and Chronic Obstructive Pulmonary Disease. [europepmc]
• Beta-blockers in patients with heart failure with reduced ejection fraction and concomitant chronic obstructive pulmonary disease: Cardiovascular and respiratory outcomes. [europepmc]
• Heart failure and chronic obstructive pulmonary disease. A combination not to be underestimated. [europepmc]
• Association between β-blocker use and outcomes in patients with heart failure and chronic obstructive pulmonary disease: a retrospective cohort study. [europepmc]
• Associations Between Albumin-Corrected Anion Gap and Mortality in Heart Failure Patients with Chronic Obstructive Pulmonary Disease: A Retrospective Cohort Study. [europepmc]
• Acute Exacerbations of Chronic Lung Disease: Cardiac Considerations [europepmc]